Nachrichten zur Johnson Matthey PLC Aktie

Johnson & Johnson (JNJ) Could Be a Great Choice

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

The Zacks Analyst Blog JPMorgan, Johnson & Johnson, Applied Materials and Value Line

JPMorgan, Johnson & Johnson and Applied Materials stand out in new research reports, highlighting strong business momentum despite industry and…

JNJ Seeks Label Expansion of Multiple Myeloma Drug Tecvayli in the EU

Johnson & Johnson seeks EMA nod to expand Tecvayli monotherapy use in earlier-line RRMM, backed by phase III MajesTEC-9 data…

Johnson & Johnson Aktie: Medizintechnik-Sektor weiter in starker Verfassung

New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse der Citigroup:Citi habe das Kursziel für die Aktie von Johnson & Johnson (J&J)…

Scherbaums Börse: Die Stärke von Johnson & Johnson

Donald Trump zwingt Pharmakonzerne zu Preisnachlässen. Doch ausgerechnet Johnson & Johnson liefert überraschend starke Zahlen. Anleger stellen sich nun eine…

Johnson & Johnson (JNJ) Declines More Than Market: Some Information for Investors

In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $239.63, denoting a -2.31% move from…

Johnson & Johnson launches website for direct-to-consumer sales

Johnson & Johnson has launched a website to sell some of its drugs directly to U.S. patients who either dont…

Johnson & Johnson launches website for direct-to-consumer sales

Johnson & Johnson launches website for direct-to-consumer sales…

Johnson & Johnson Aktie: BofA sieht mehr Umsatzpotenzial - Fokus auf Tecvayli und Inlexzo

Charlotte (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von BofA Securities:Jason Gerberry, Analyst von BofA Securities, stuft die Aktie von Johnson &…

Johnson & Johnson (JNJ) Advances While Market Declines: Some Information for Investors

Johnson & Johnson (JNJ) closed the most recent trading day at $248.43, moving +2.04% from the previous trading session.…

Are You Looking for a High-Growth Dividend Stock?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Bayer verklagt Johnson & Johnson – Aktie fällt und fällt

Der DAX-Konzern Bayer will sich in den Vereinigten Staaten juristisch gegen Johnson & Johnson wehren. Der Hintergrund für die Klage…

Bayer verklagt Johnson & Johnson – Aktie fällt und fällt

Der DAX-Konzern Bayer will sich in den Vereinigten Staaten juristisch gegen Johnson & Johnson wehren. Der Hintergrund für die Klage…

Bayer verklagt Johnson & Johnson wegen irreführender Werbung

Von Nicholas G. Miller DOW JONES--Die Bayer AG verklagt Johnson Johnson (JJ) und deren Sparte Janssen Biotech wegen…

Johnson & Johnson vs. AbbVie: A Growth Showdown Amid Patent Cliffs

JNJs diversified model, $32B R&D push and 48% stock surge in a year raise the stakes in its battle with…

Johnson & Johnson: This Dividend King Could Anchor a Millionaire Retirement Portfolio

Its about striking that perfect balance between chasing growth and protecting what you already have.…

Honeywell Considers Walking Away From Johnson Matthey Catalyst Deal

Honeywell International Inc. is considering walking away from its acquisition of Johnson Matthey Plc’s Catalyst Technologies business, people familiar with…

Why Is Johnson & Johnson (JNJ) Up 13% Since Last Earnings Report?

Johnson & Johnson (JNJ) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings…

Johnson & Johnson explores $20 billion sale of an orthopedics unit, Bloomberg News reports By Reuters

Johnson & Johnson explores $20 billion sale of an orthopedics unit, Bloomberg News reports…

Johnson & Johnson prepares to sell orthopedics unit for over $20 billion

Johnson & Johnson prepares to sell orthopedics unit for over $20 billion - Bloomberg…

Johnson & Johnson to invest $1B in Pennsylvania manufacturing facility

Johnson & Johnson announced a $1 billion investment in a Montgomery County, Pennsylvania, cell therapy facility that will yield over…

Johnson & Johnson investing $1B to build new cell therapy facility in Montgomery County

Johnson & Johnson is investing more than $1 billion to build a new cell therapy plant in Montgomery County.…

Johnson & Johnson to Invest More Than $1 Billion in Pennsylvania Cell Therapy Factory

The facility is part of the company’s plans to invest $55 billion in U.S. manufacturing, research and development and technology…

J&J to invest $1 billion in new Pennsylvania plant amid US manufacturing push

Johnson & Johnson said on Wednesday it will invest more than $1 billion to build a new cell therapy facility…

Johnson & Johnson Expands U.S. Footprint with more than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania

• Advanced manufacturing site will utilize cutting?edge cell therapy technologies to help deliver the company’s portfolio of transformational medicines •…

Pennsylvania jury finds Johnson & Johnson liable for cancer in latest talc trial By Reuters

Pennsylvania jury finds Johnson & Johnson liable for cancer in latest talc trial…

Johnson & Johnson ordered to pay $250,000 in talc powder lawsuit By Investing.com

Johnson & Johnson ordered to pay $250,000 in talc powder lawsuit…

Johnson & Johnson: Starke Pipeline, teure Aktie

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse der Raiffeisen Bank International AG (RBI):Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI),…

3 Earnings Winners Holding Strong in a Range-Bound Market

Market Analysis by covering: Nasdaq 100, S&P 500, Johnson & Johnson, Meta Platforms Inc. Read s Market Analysis on…

Is Johnson & Johnson a Buy, Sell, or Hold in 2026?

This reliable dividend payer may be just what the doctor ordered.…

Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

This Top Dividend Stock Could Achieve a Major Milestone This Year. Is It a Buy?

Johnson & Johnson is a picture of stability.…

The Zacks Analyst Blog Johnson & Johnson, Netflix, Arista Networks, Omega and AXIL

Johnson & Johnson leads Zacks latest Analyst Blog as new research highlights earnings beats, growth drivers, and risks across major…

Top Stock Reports for Johnson & Johnson, Netflix & Arista Networks

JNJs Q4 beat, Netflixs subscriber surge, and Arista Networks cloud demand highlight why these stocks headline todays top research reports.…

Morgan Stanley upgrades Johnson & Johnson, sees upside on robust drug pipeline

Morgan Stanleys price target implies that shares of Johnson & Johnson could rise another 17%.…

Johnson & Johnson Aktie: Neues Produktportfolio sorgt für Analysten-Upgrade!

New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Morgan Stanley:Die Analysten von Morgan Stanley stufen die Aktie von Johnson &…

Johnson & Johnson Aktie: "Top Pick" im Segment der Large-Cap-Biopharmawerte

New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Guggenheim Securities:Guggenheim-Analyst Vamil Divan habe das Kursziel für die Aktie von Johnson…

Johnson & Johnson Aktie: Solide Basis für langfristige Anleger

Frankfurt (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von XTB:Die Experten von XTB nehmen die Aktie der Johnson & Johnson (J&J) (ISIN:…

Johnson & Johnson Aktie: Überraschend starke Zahlen - Startet jetzt die nächste Rally?

New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von TD Cowen:TD Cowen-Analyst Joshua Jennings habe das Kursziel für die Aktie von…

Johnson & Johnson Aktie: Starkes Setup - Kommt jetzt das nächste Top-Jahr für die Aktie?

New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Goldman Sachs:Goldman-Sachs-Analyst Asad Haider habe das Kursziel für die Aktie von Johnson…

Johnson & Johnson Aktie: Zweistelliges Wachstum im Visier!

San Francisco (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Wells Fargo Advisors:Wells Fargo habe das Kursziel für die Aktie von Johnson…

Johnson & Johnson Aktie: Solide Q4-Zahlen - aber jetzt kommt der Bewertungs-Haken

Charlotte (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von BofA Securities:BofA-Analyst Jason Gerberry habe das Kursziel für die Aktie von Johnson &…

Johnson & Johnson Aktie: Q4-Überraschung und ein Plan für zweistelliges Wachstum!

New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Morgan Stanley:Morgan-Stanley-Analyst Terence Flynn habe das Kursziel für die Aktie von Johnson…

Gewinn- sowie Umsatzwachstum bei Johnson & Johnson - Aktien von Netflix und Kraft Heinz unter Druck

Wien (www.aktiencheck.de) - Netflix gab um 2% nach, nachdem die Geschäftszahlen nicht in allen Punkten überzeugen konnten, so die Analysten…

This 2.4%-Yielding Dividend King Remains As Healthy As Ever

Johnson & Johnson had a strong year.…

MDAI: In the Blocks, Ready to Go upon Mid-Year Authorization

By John Vandermosten, CFANASDAQ:MDAIREAD THE FULL MDAI RESEARCH REPORTIt has now been approximately seven months since Spectral AI, Inc. (NASDAQ:MDAI)…

Johnson & Johnson (JNJ) Reports Q4 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Johnson & Johnson (JNJ) give a sense of how the business performed in…

Johnson & Johnson (JNJ) Tops Q4 Earnings and Revenue Estimates

Johnson & Johnson (JNJ) delivered earnings and revenue surprises of +1.05% and +1.84%, respectively, for the quarter ended December 2025.…

Market movers: Kraft Heinz, Lisata Therapeutics, Halliburton, Johnson & Johnson...

…

Johnson & Johnson Quartalszahlen Q4: Jahresprognose über Erwartungen

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse der Raiffeisen Bank International AG (RBI):Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI),…